Cargando…
Acidosis significantly alters immune checkpoint expression profiles of T cells from oesophageal adenocarcinoma patients
Tumour acidosis contributes to cancer progression by inhibiting anti-tumour immunity. However, the effect of acidosis on anti-tumour T cell phenotypes in oesophageal adenocarcinoma (OAC) is unknown. Therefore, this study investigated the effect of acidosis on anti-tumour T cell profiles and if immun...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813044/ https://www.ncbi.nlm.nih.gov/pubmed/35708739 http://dx.doi.org/10.1007/s00262-022-03228-y |
_version_ | 1784863846706446336 |
---|---|
author | Davern, Maria Donlon, Noel E. O’Connell, Fiona Gaughan, Caoimhe O’Donovan, Cillian Habash, Mohammed Sheppard, Andrew D. MacLean, Michael Dunne, Margaret R. Moore, Jenny Temperley, Hugo Conroy, Melissa J. Butler, Christine Bhardwaj, Anshul Ravi, Narayanasamy Donohoe, Claire L. Reynolds, John V. Lysaght, Joanne |
author_facet | Davern, Maria Donlon, Noel E. O’Connell, Fiona Gaughan, Caoimhe O’Donovan, Cillian Habash, Mohammed Sheppard, Andrew D. MacLean, Michael Dunne, Margaret R. Moore, Jenny Temperley, Hugo Conroy, Melissa J. Butler, Christine Bhardwaj, Anshul Ravi, Narayanasamy Donohoe, Claire L. Reynolds, John V. Lysaght, Joanne |
author_sort | Davern, Maria |
collection | PubMed |
description | Tumour acidosis contributes to cancer progression by inhibiting anti-tumour immunity. However, the effect of acidosis on anti-tumour T cell phenotypes in oesophageal adenocarcinoma (OAC) is unknown. Therefore, this study investigated the effect of acidosis on anti-tumour T cell profiles and if immune checkpoint blockade (ICB) could enhance anti-tumour T cell immunity under acidosis. Acidic conditions substantially altered immune checkpoint expression profiles of OAC patient-derived T cells, upregulating TIM-3, LAG-3 and CTLA-4. Severe acidosis (pH 5.5) significantly decreased the percentage of central memory CD4(+) T cells, an effect that was attenuated by ICB treatment. ICB increased T cell production of IFN-γ under moderate acidosis (pH 6.6) but not severe acidosis (pH 5.5) and decreased IL-10 production by T cells under severe acidic conditions only. A link between lactate and metastasis was also depicted; patients with nodal metastasis had higher serum lactate levels (p = 0.07) which also positively correlated with circulating levels of pro-angiogenic factor Tie-2. Our findings establish that acidosis-induced upregulation of immune checkpoints on T cells may potentially contribute to immune evasion and disease progression in OAC. However, acidic conditions curtailed ICB efficacy, supporting a rationale for utilizing systemic oral buffers to neutralize tumour acidity to improve ICB efficacy. GRAPHICAL ABSTRACT: Study schematic—PBMCs were isolated from OAC patients (A) and expanded ex vivo for 7 days using anti-CD3/28 +IL-2 T cell activation protocol (B) and further cultured for 48 h under increasing acidic conditions in the absence or presence of immune checkpoint blockade (nivolumab, ipilimumab or dual nivolumab + ipilimumab) (C). Immunophenotyping was then carried out to assess immune checkpoint expression profiles and anti-tumour T cell phenotypes (D). Serum lactate was assessed in OAC patients (E–F) and levels were correlated with patient demographics (G) and the levels of circulating immune/pro-angiogenic cytokines that were determined by multiplex ELISA (H). Key Findings—severe acidic conditions upregulated multiple immune checkpoints on T cells (I). Efficacy of ICB was curtailed under severe acidic conditions (J). Circulating lactate levels positively correlated with circulating levels of pro-angiogenic factor tie-2 and higher serum lactate levels were found in patients who had nodal metastasis (K). [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00262-022-03228-y. |
format | Online Article Text |
id | pubmed-9813044 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-98130442023-01-06 Acidosis significantly alters immune checkpoint expression profiles of T cells from oesophageal adenocarcinoma patients Davern, Maria Donlon, Noel E. O’Connell, Fiona Gaughan, Caoimhe O’Donovan, Cillian Habash, Mohammed Sheppard, Andrew D. MacLean, Michael Dunne, Margaret R. Moore, Jenny Temperley, Hugo Conroy, Melissa J. Butler, Christine Bhardwaj, Anshul Ravi, Narayanasamy Donohoe, Claire L. Reynolds, John V. Lysaght, Joanne Cancer Immunol Immunother Original Article Tumour acidosis contributes to cancer progression by inhibiting anti-tumour immunity. However, the effect of acidosis on anti-tumour T cell phenotypes in oesophageal adenocarcinoma (OAC) is unknown. Therefore, this study investigated the effect of acidosis on anti-tumour T cell profiles and if immune checkpoint blockade (ICB) could enhance anti-tumour T cell immunity under acidosis. Acidic conditions substantially altered immune checkpoint expression profiles of OAC patient-derived T cells, upregulating TIM-3, LAG-3 and CTLA-4. Severe acidosis (pH 5.5) significantly decreased the percentage of central memory CD4(+) T cells, an effect that was attenuated by ICB treatment. ICB increased T cell production of IFN-γ under moderate acidosis (pH 6.6) but not severe acidosis (pH 5.5) and decreased IL-10 production by T cells under severe acidic conditions only. A link between lactate and metastasis was also depicted; patients with nodal metastasis had higher serum lactate levels (p = 0.07) which also positively correlated with circulating levels of pro-angiogenic factor Tie-2. Our findings establish that acidosis-induced upregulation of immune checkpoints on T cells may potentially contribute to immune evasion and disease progression in OAC. However, acidic conditions curtailed ICB efficacy, supporting a rationale for utilizing systemic oral buffers to neutralize tumour acidity to improve ICB efficacy. GRAPHICAL ABSTRACT: Study schematic—PBMCs were isolated from OAC patients (A) and expanded ex vivo for 7 days using anti-CD3/28 +IL-2 T cell activation protocol (B) and further cultured for 48 h under increasing acidic conditions in the absence or presence of immune checkpoint blockade (nivolumab, ipilimumab or dual nivolumab + ipilimumab) (C). Immunophenotyping was then carried out to assess immune checkpoint expression profiles and anti-tumour T cell phenotypes (D). Serum lactate was assessed in OAC patients (E–F) and levels were correlated with patient demographics (G) and the levels of circulating immune/pro-angiogenic cytokines that were determined by multiplex ELISA (H). Key Findings—severe acidic conditions upregulated multiple immune checkpoints on T cells (I). Efficacy of ICB was curtailed under severe acidic conditions (J). Circulating lactate levels positively correlated with circulating levels of pro-angiogenic factor tie-2 and higher serum lactate levels were found in patients who had nodal metastasis (K). [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00262-022-03228-y. Springer Berlin Heidelberg 2022-06-16 2023 /pmc/articles/PMC9813044/ /pubmed/35708739 http://dx.doi.org/10.1007/s00262-022-03228-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Davern, Maria Donlon, Noel E. O’Connell, Fiona Gaughan, Caoimhe O’Donovan, Cillian Habash, Mohammed Sheppard, Andrew D. MacLean, Michael Dunne, Margaret R. Moore, Jenny Temperley, Hugo Conroy, Melissa J. Butler, Christine Bhardwaj, Anshul Ravi, Narayanasamy Donohoe, Claire L. Reynolds, John V. Lysaght, Joanne Acidosis significantly alters immune checkpoint expression profiles of T cells from oesophageal adenocarcinoma patients |
title | Acidosis significantly alters immune checkpoint expression profiles of T cells from oesophageal adenocarcinoma patients |
title_full | Acidosis significantly alters immune checkpoint expression profiles of T cells from oesophageal adenocarcinoma patients |
title_fullStr | Acidosis significantly alters immune checkpoint expression profiles of T cells from oesophageal adenocarcinoma patients |
title_full_unstemmed | Acidosis significantly alters immune checkpoint expression profiles of T cells from oesophageal adenocarcinoma patients |
title_short | Acidosis significantly alters immune checkpoint expression profiles of T cells from oesophageal adenocarcinoma patients |
title_sort | acidosis significantly alters immune checkpoint expression profiles of t cells from oesophageal adenocarcinoma patients |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813044/ https://www.ncbi.nlm.nih.gov/pubmed/35708739 http://dx.doi.org/10.1007/s00262-022-03228-y |
work_keys_str_mv | AT davernmaria acidosissignificantlyaltersimmunecheckpointexpressionprofilesoftcellsfromoesophagealadenocarcinomapatients AT donlonnoele acidosissignificantlyaltersimmunecheckpointexpressionprofilesoftcellsfromoesophagealadenocarcinomapatients AT oconnellfiona acidosissignificantlyaltersimmunecheckpointexpressionprofilesoftcellsfromoesophagealadenocarcinomapatients AT gaughancaoimhe acidosissignificantlyaltersimmunecheckpointexpressionprofilesoftcellsfromoesophagealadenocarcinomapatients AT odonovancillian acidosissignificantlyaltersimmunecheckpointexpressionprofilesoftcellsfromoesophagealadenocarcinomapatients AT habashmohammed acidosissignificantlyaltersimmunecheckpointexpressionprofilesoftcellsfromoesophagealadenocarcinomapatients AT sheppardandrewd acidosissignificantlyaltersimmunecheckpointexpressionprofilesoftcellsfromoesophagealadenocarcinomapatients AT macleanmichael acidosissignificantlyaltersimmunecheckpointexpressionprofilesoftcellsfromoesophagealadenocarcinomapatients AT dunnemargaretr acidosissignificantlyaltersimmunecheckpointexpressionprofilesoftcellsfromoesophagealadenocarcinomapatients AT moorejenny acidosissignificantlyaltersimmunecheckpointexpressionprofilesoftcellsfromoesophagealadenocarcinomapatients AT temperleyhugo acidosissignificantlyaltersimmunecheckpointexpressionprofilesoftcellsfromoesophagealadenocarcinomapatients AT conroymelissaj acidosissignificantlyaltersimmunecheckpointexpressionprofilesoftcellsfromoesophagealadenocarcinomapatients AT butlerchristine acidosissignificantlyaltersimmunecheckpointexpressionprofilesoftcellsfromoesophagealadenocarcinomapatients AT bhardwajanshul acidosissignificantlyaltersimmunecheckpointexpressionprofilesoftcellsfromoesophagealadenocarcinomapatients AT ravinarayanasamy acidosissignificantlyaltersimmunecheckpointexpressionprofilesoftcellsfromoesophagealadenocarcinomapatients AT donohoeclairel acidosissignificantlyaltersimmunecheckpointexpressionprofilesoftcellsfromoesophagealadenocarcinomapatients AT reynoldsjohnv acidosissignificantlyaltersimmunecheckpointexpressionprofilesoftcellsfromoesophagealadenocarcinomapatients AT lysaghtjoanne acidosissignificantlyaltersimmunecheckpointexpressionprofilesoftcellsfromoesophagealadenocarcinomapatients |